PACTR202209738652499
Other
未知
Intralesional Injection of Ethanolamine Oleate Alone or Mixed with Bupivacaine in Oral Venous Malformation (Randomized Controlled Trial)
Oral and Maxillofacial Surgery Department Faculty of Dentistry Alexandria University0 sites16 target enrollmentSeptember 12, 2022
ConditionsOral Health
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Oral Health
- Sponsor
- Oral and Maxillofacial Surgery Department Faculty of Dentistry Alexandria University
- Enrollment
- 16
- Status
- Other
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients suffering from oral vascular malformations with a size of 2\- 4 cm
Exclusion Criteria
- •High flow vascular malformations.
- •Patient’s medication interfering with coagulation and wound healing(e.g., steroids, bisphosphonates, anticoagulants) or specific states preventing the use of EAO (e.g., pregnancy, lactation).
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Complications of Ethanol-amine Oleate Intralesional SclerotherapyVenous MalformationNCT04930952Suez Canal University15
Not yet recruiting
Phase 3
Comparing pain on intravenous injection while using two formulations of etomidate.Health Condition 1: O- Medical and SurgicalCTRI/2021/03/032358Madhuri Kumari
Completed
Not Applicable
Sclerotherapy with Ethanolamine Oleate of Oral Vascular Anomalies: What is the Ideal Concentration?Diseases of the circulatory system, Endothelium vascularA07.231.700.500RBR-9xcx69Faculdade de Odontologia da Universidade Federal de Minas Gerais
Completed
Not Applicable
Percutaneous ethanol injection in benign thyroid nodulesbenign thyroid nodules.Nontoxic single thyroid noduleE04.1IRCT20240718062461N1Islamic Azad University52
Completed
Phase 3
CITOPROT-IIIDiabetic foot ulcer.Diabetic FootFoot UlcerLeg UlcerSkin UlcerDiabetic AngiopathiesVascular DiseasesDiabetes ComplicationsDiabetic NeuropathiesDiabetes MellitusEndocrine System DiseasesCardiovascular DiseasesRPCEC00000060Center for Genetic Engineering and Biothecnology (CIGB), Havana.147